Streetbeat News

TCNNF

Trulieve Cannabis Corp

Employees

9,000

Industry

Medicinal and Botanical Manufacturing

Open

4.00

Mkt cap

795M

Volume

20K

High

4.20

P/E Ratio

-5.27

52-wk high

14.50

Low

4.00

Div yield

N/A

52-wk low

3.99

The article reports on the stock movements of various marijuana-related companies for July 25, 2024. Notable gainers include Leafbuyer Techs, Cansortium, and Psychemedics, while significant losers include Blueberries Medical, 1933 Industries, and Greenlane Holdings.

Portfolio Pulse from Benzinga Insights

July 25, 2024 | 8:30 pm

Florida Governor Ron DeSantis criticized the state's cannabis legalization initiative, Amendment 3, stating it should not have been allowed on the ballot due to misleading summaries. Despite his opposition, recent polls show strong support for the initiative. Trulieve Cannabis Corp has invested heavily in promoting the measure.

Portfolio Pulse from Maureen Meehan

July 25, 2024 | 4:42 pm

The article reports on the performance of various cannabis stocks on July 24, 2024. Notable gainers include Global Hemp Group, CordovaCann, and 22nd Century Group, while significant losers include Green Growth Brands, Leafbuyer Techs, and Canopy Growth.

Portfolio Pulse from Benzinga Insights

July 24, 2024 | 8:30 pm

Caleb Counts, CEO of Connected Cannabis Co., discussed the company's journey from humble beginnings to becoming a celebrity favorite, with endorsements from artists like Travis Scott and ASAP Rocky. The company focuses on premium strains, sustainability, and expansion beyond California, including a key partnership with Trulieve Cannabis in Florida.

Portfolio Pulse from Patricio Liddle

July 24, 2024 | 2:12 pm

New cannabis dispensaries are opening across the U.S., including Trulieve's new store in Pennsylvania, Dark Horse Cannabis's headquarters in Arkansas, Bloom Montana's new location in Bozeman, and Snoop Dogg's first licensed store near LAX. Trulieve is expanding its footprint in Pennsylvania, potentially positioning itself for recreational legalization.

Portfolio Pulse from Jelena Martinovic

July 23, 2024 | 4:39 pm

Cannabis stocks and ETFs saw significant movement following President Joe Biden's announcement that he will not seek re-election. Key stocks like Aurora Cannabis, Village Farms International, Tilray Brands, and SNDL experienced notable gains. Multi-state operators and cannabis ETFs also saw positive performance.

Portfolio Pulse from Nicolás Jose Rodriguez

July 22, 2024 | 10:12 pm

Cannabis stocks experienced significant volatility following President Joe Biden's announcement that he will not seek re-election. Some stocks surged while others plummeted, reflecting investor sentiment and market speculation about future regulatory changes. Cannabis ETFs also showed mixed performance, indicating cautious optimism among investors.

Portfolio Pulse from Nicolás Jose Rodriguez

July 22, 2024 | 6:12 pm

A DeSantis-backed coalition has launched a campaign to defeat Florida's cannabis legalization initiative, Amendment 3, which needs 60% voter support to pass in November 2024. Despite strong opposition from Gov. Ron DeSantis and the Republican Party, the amendment has significant support, including from Florida's largest medical marijuana company, Trulieve (OTC:TCNNF), which has invested over $40 million in the campaign.

Portfolio Pulse from Maureen Meehan

July 21, 2024 | 4:51 pm

Florida's medical cannabis market is experiencing significant growth ahead of the November 2024 legalization ballot. The number of qualified patients has increased by 195.7% since January 2020, while the number of dispensing locations has more than tripled. Leading companies like Trulieve, Curaleaf, and MÜV have expanded their operations significantly.

Portfolio Pulse from Rolando García

July 20, 2024 | 7:17 pm

European cannabis companies are planning IPOs on Nasdaq, driven by potential regulatory changes in the US and Germany. Companies like Grow Group, Somai Pharmaceuticals, and Wellford Medical are eyeing Nasdaq listings. US companies Curaleaf and Trulieve could benefit from tax breaks if cannabis is rescheduled to Schedule III. IM Cannabis and InterCure are also poised for growth in the European market.

Portfolio Pulse from Nicolás Jose Rodriguez

July 18, 2024 | 7:25 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.